Several lines of evidence indicate that chronic inflammation in rheumatoid arthritis (RA) may be induced by immune mechanisms, among which the liberation and persistence of antigen in the intraarticular space could be of considerable importance. After induction of local antibody production in the synovial tissue the antigen may engage in the formation of antigen-antibody complexes. The nature of the antigen(s) involved is still uncertain. One of the major components of joint tissue is collagen.
Using the antiglobulin consumption test and bovine collagen as antigen, Steffen and others (1968) showed collagen antibodies in 39-8% of 276 RA sera. In classifying these cases according to the severity of disease, 88 % of cases with a severe and rapidly progressive form of RA had collagen antibodies, while only 29-2% of patients with a mild or less severe course of disease had these antibodies. In 99 control cases only 10 sera showed collagen antibodies. Using human collagen as antigen, Steffen and others (1973) obtained similar results with 238 RA sera and 50 control sera. Michaeli and Fudenberg (1974) confirmed these findings with the haemagglutination technique in showing anticollagen antibodies in about 60% of 100 arthritis sera and about 9% of 400 age-and sex-matched control sera. Steffen and others (1971) , using the antiglobulin consumption test, showed anticollagen antibodies in RA synovial fluids and proved the autoantibody property of these antibodies. In a recent study, Cracchiolo and others (1975) also showed antibodies to denatured and native collagen in RA synovial fluids. With doublestaining immunofluorescence, Steffen, Ludwig, and Knapp (1974) observed that collagen and IgG were located in identical positions in inclusions of RA synovial fluids, indicating the presence of collagenanticollagen complexes.
The demonstration of immune complexes by enzymatic cleavage of the antigen was introduced j,.iby Harbeck and others (1973) . Menzel (1976) Acid soluble collagen (ASC) was prepared from human baby dura mater according to Steffen and Timpl (1962) . The purity of the preparation, as ascertained by hydroxyproline determination according to Stegemann (1958) , was 96%. Amino acid analysis was consistent with it being essentially type I collagen. For serological investigations and in vitro preparation of collagenanticollagen complexes the lyophilized ASC was dissolved in 0 1 % acetic acid to a concentration of 100 mg/100 ml. In order to obtain denatured acid soluble collagen (DASC), this solution was heated for 30 minutes at 40°C.
PASSIVE HAEMAGGLUTINATION AND HAEMAG-GLUTINATION-INHIBITION
Haemagglutination was performed according to Steffen, Timpl, and Wolff (1964) . In the treatment of synovial fluids with collagenase in solution samples were serially diluted after enzymatic treatment with PBS containing 0-01 mol/l EDTA to inhibit collagenase activity. If carrier-bound collagenase was used, dilutions were performed with PBS.
COLLAGENASE-TREATMENT OF IN VITRO PREPARED IMMUNE COMPLEXES
Rabbits were immunized with DASC as described by Steffen and Timpl (1962) . An antiserum with an anticollagen titre of 1: 2048 was used for the preparation of collagen-anticollagen complexes. In haemagglutinationinhibition the concentration of DASC necessary to completely inhibit the antiserum was determined. A series of antiserum/antigen-mixtures containing increasing amounts of DASC up to the twofold concentration necessary for complete inhibition was incubated for 30 minutes at 37°C. Aliquots of these immune complex preparations were tested in passive haemagglutination before and after collagenase digestion.
LATEX-TEST FOR RHEUMATOID FACTOR
Antiglobulin activity of synovial fluids was determined with latex particles coated with aggregated human IgG (Behringwerke, W. Germany). Table IV gives the results obtained with synovial fluids from control patients. Defining again titres higher than 1: 8 as distinctly positive, only one of 10 synovial fluids showed the presence of anticollagen antibodies.
Discussion
Investigations by different groups (Steffen and others, 1968; Kriegel and others, 1970; Michaeli and Fudenberg, 1974; Steffen and others, 1973; Frank, 1974) showed that 40 to 50% of sera from RA patients contain antibodies to denatured collagen, while only about 10% of healthy individuals were found to have these antibodies. In addition to the markedly higher incidence of anticollagen antibodies, patients with RA have significantly higher anticollagen titres than control patients. Anticollagen titres in RA patients are furthermore found to increase with the severity of disease (Steffen and others, 1968; Frank, 1974) . Anticollagen antibodies were also shown in RA synovial fluids (Steffen and others, 1971; Cracchiolo and others, 1975) .
Further studies in this field showed that collagenanticollagen complexes prepared in vitro are ingested by phagocytosing cells (Steffen and others, 1974) , that collagen as well as collagen-anticollagen complexes can be observed as inclusions in RA synovial fluid cells (Steffen and others, 1972) , and that collagen-anticollagen complexes prepared in vitro possess inflammatory activity as shown in passive cutaneous anaphylaxis (Menzel and Steffen, 1975) . Injection of collagen into the knee joints of collagen-immunized rabbits induced experimental arthritis (Steffen and others, 1975) . These findings indicate a possible pathogenetic role of collagenanticollagen immune complexes in RA (Steffen, 1970) . To obtain further evidence on the involvement of anticollagen antibodies and collagenanticollagen complexes in RA, synovial fluids of RA patients and controls were investigated with regard to the presence of such immune complexes. This study was restricted to synovial fluids since earlier investigations had shown that a correlation exists between the presence of anticollagen antibodies in sera and synovial fluids (Cracchiolo and others, 1975) .
To determine the proportions of free and complex-bound anticollagen antibodies, collagenase digestion was used., Similar experiments were performed by Harbeck and others (1973) , who used DNAse to show DNA-anti-DNA immune complexes. In preliminary in vitro experiments we showed that collagen can be digested by collagenase of bacterial origin even after forming complexes with anticollagen antibodies. The enzymatic digestion of the antigen causes the disruption of the immune complexes and the liberation ofreactive antibodies. In further studies Menzel (1976) showed that collagen-anticollagen complexes prepared in vitro, which were isolated by gel filtration, can also be disrupted by using identical methods of collagenase digestion as described in this study.
Our results show that 22 of the 29 RA synovial fluids investigated contained anticollagen antibodies with titres up to 1: 512. In 15 of these antibodypositive fluids part or all of the antibodies were present as immune complexes ('hidden' antibodies). These results are based on defining an antibody titre higher than 1: 8 as distinctly positive and on considering an increase in titre after collagenase digestion of at least two steps as significant for the demonstration of immune complexes. Anticollagen antibody titre or the amount of collagen-anticollagen complexes appeared to be unrelated to the presence of rheumatoid factors. This finding corresponds to the results obtained by Cracchiolo and others (1975) .
In the non-RA group of 10 patients, 2 had nonsignificant anticollagen titres of 1: 2 and 1: 4, while only one showed a titre of 1: 32, which was, however, not altered by collagenase digestion.
To avoid any artefactual effects on haemag-glutination due to differences in the viscosity of synovial fluids, all fluids were digested with hyaluronidase. Cracchiolo and others (1975) used for the same reason caesium chloride density gradient ultracentrifugation to separate hyaluronate protein from immunoglobulins. The use ofhyaluronidase, which degrades glycosaminoglycans such as hyaluronate and chondroitin sulphate, has an additional advantage. It is possible that interaction between collagen-coated erythrocytes and glycosaminoglycans present in the synovial fluids simulates an antigen-antibody reaction in passive haemagglutination by aggregating the red blood cells nonspecifically (Conochie, Scott, and Faulk, 1975) . However, as the synovial fluids investigated by us were digested with hyaluronidase, a large part of the glycosaminoglycans could be eliminated by dialysis. We observed furthermore that no agglutination of human erythrocytes coated with denatured collagen was caused by incubation of these cells with chondroitin-4-sulphate or chondroitin-6-sulphate up to a concentration of 1 mg/ml. Our findings suggest that anticollagen antibodies and/or immune complexes of collagen exist in RA synovial fluids. The presence of anticollagen antibodies could be due to chronic antigenic stimulation of immunocytes in the synovial tissue induced by products of enzyme-mediated collagen breakdown. Antibodies to collagen may form immune complexes by reacting with collagen debris set free by enzymatic action. The importance of such complexes for the pathogenesis or chronic perpetuation of RA and their possible effect on progressive cartilage destruction remains to be investigated. 
